NASDAQ:RPTP - Raptor Pharmaceutical Stock Price, Price Target & More

$9.00 0.00 (0.00 %)
(As of 04/24/2018 02:27 PM ET)
Previous Close$9.00
Today's Range$8.95 - $9.05
52-Week Range$2.94 - $9.05
Volume753,200 shs
Average Volume1.42 million shs
Market Capitalization$767.76 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A

About Raptor Pharmaceutical (NASDAQ:RPTP)

Raptor Pharmaceutical logoRaptor Pharmaceutical Corp. (Raptor) is a biopharmaceutical company. The Company is focused on developing and commercializing transformative treatments for people affected by diseases. Its product, PROCYSBI (cysteamine bitartrate) is a delayed-release capsules for the management of nephropathic cystinosis in adults and children of over six years. In Europe, PROCYSBI gastro-resistant hard capsules of cysteamine (as mercaptamine bitartrate), is indicated as an orphan medicinal product for the management of nephropathic cystinosis. Its QUINSAIR is a formulation of the antibiotic drug levofloxacin, suitable for inhalation via a nebulizer. It is engaged in developing MP-376 for non-CF bronchiectasis (BE) and nontuberculous mycobacteria (NTM) lung infections. It is also engaged in developing RP105 and RP106 for various diseases.

Receive RPTP News and Ratings via Email

Sign-up to receive the latest news and ratings for RPTP and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry N/A
Sub-IndustryBiotechnology
SectorN/A
SymbolNASDAQ:RPTP
CUSIP75382F10
Phone+1-415-4086200

Debt

Debt-to-Equity Ratio1.33%
Current Ratio3.57%
Quick Ratio3.30%

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net Margins-43.75%
Return on Equity-77.01%
Return on Assets-15.64%

Miscellaneous

Employees158
Outstanding Shares85,310,000

How to Become a New Pot Stock Millionaire

Raptor Pharmaceutical (NASDAQ:RPTP) Frequently Asked Questions

What is Raptor Pharmaceutical's stock symbol?

Raptor Pharmaceutical trades on the NASDAQ under the ticker symbol "RPTP."

How were Raptor Pharmaceutical's earnings last quarter?

Raptor Pharmaceutical Corp (NASDAQ:RPTP) announced its quarterly earnings results on Thursday, August, 4th. The biotechnology company reported ($0.16) earnings per share for the quarter, beating the consensus estimate of ($0.18) by $0.02. The biotechnology company earned $32.05 million during the quarter, compared to analysts' expectations of $28.52 million. Raptor Pharmaceutical had a negative return on equity of 77.01% and a negative net margin of 43.75%. Raptor Pharmaceutical's quarterly revenue was up 37.4% on a year-over-year basis. During the same period last year, the business earned ($0.17) earnings per share. View Raptor Pharmaceutical's Earnings History.

Has Raptor Pharmaceutical been receiving favorable news coverage?

Media headlines about RPTP stock have been trending somewhat positive recently, according to Accern Sentiment Analysis. The research group rates the sentiment of news coverage by monitoring more than 20 million news and blog sources. Accern ranks coverage of public companies on a scale of negative one to one, with scores nearest to one being the most favorable. Raptor Pharmaceutical earned a coverage optimism score of 0.14 on Accern's scale. They also gave press coverage about the biotechnology company an impact score of 45.28 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the stock's share price in the next few days.

How do I buy shares of Raptor Pharmaceutical?

Shares of RPTP can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Raptor Pharmaceutical's stock price today?

One share of RPTP stock can currently be purchased for approximately $9.00.

How big of a company is Raptor Pharmaceutical?

Raptor Pharmaceutical has a market capitalization of $767.76 million. Raptor Pharmaceutical employs 158 workers across the globe.

How can I contact Raptor Pharmaceutical?

Raptor Pharmaceutical's mailing address is 7 Hamilton Lndg Ste 100, NOVATO, CA 94949-8283, United States. The biotechnology company can be reached via phone at +1-415-4086200.


MarketBeat Community Rating for Raptor Pharmaceutical (RPTP)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  195 (Vote Outperform)
Underperform Votes:  201 (Vote Underperform)
Total Votes:  396
MarketBeat's community ratings are surveys of what our community members think about Raptor Pharmaceutical and other stocks. Vote "Outperform" if you believe RPTP will outperform the S&P 500 over the long term. Vote "Underperform" if you believe RPTP will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Raptor Pharmaceutical (NASDAQ:RPTP) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: N/AN/AN/AN/A
Consensus Rating Score: N/AN/AN/AN/A
Ratings Breakdown: 0 Sell Rating(s)
0 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: N/AN/AN/AN/A
Price Target Upside: N/AN/AN/AN/A

Raptor Pharmaceutical (NASDAQ:RPTP) Consensus Price Target History

Price Target History for Raptor Pharmaceutical (NASDAQ:RPTP)

Raptor Pharmaceutical (NASDAQ:RPTP) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
9/16/2016CowenDowngradeOutperform -> Market Perform$9.00N/AView Rating Details
9/12/2016WedbushReiterated RatingNeutral$9.00 -> $4.00N/AView Rating Details
9/8/2016FBR & CoReiterated RatingHoldN/AView Rating Details
8/8/2016CitigroupDowngradeBuy -> Neutral$6.00 -> $8.00N/AView Rating Details
(Data available from 4/24/2016 forward)

Earnings

Raptor Pharmaceutical (NASDAQ:RPTP) Earnings History and Estimates Chart

Earnings by Quarter for Raptor Pharmaceutical (NASDAQ:RPTP)

Raptor Pharmaceutical (NASDAQ RPTP) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
8/4/2016Q216($0.18)($0.16)$28.52 million$32.05 millionViewListenView Earnings Details
5/5/2016Q116($0.17)($0.17)$27.17 million$27.47 millionViewN/AView Earnings Details
2/25/2016Q415($0.19)($0.17)$26.08 million$24.67 millionViewListenView Earnings Details
11/5/2015Q315($0.18)($0.18)$24.25 million$25.80 millionViewListenView Earnings Details
8/6/2015Q215($0.21)($0.12)$21.40 million$23.30 millionViewN/AView Earnings Details
5/7/2015Q115($0.25)($0.24)$19.10 million$20.50 millionViewN/AView Earnings Details
2/26/2015Q414($0.14)($0.25)$20.12 million$17.30 millionViewN/AView Earnings Details
11/6/2014Q314($0.18)($0.04)$18.90 million$23.80 millionViewN/AView Earnings Details
8/7/2014Q214($0.19)($0.15)$14.58 million$16.31 millionViewN/AView Earnings Details
5/8/2014Q413($0.17)($0.20)$11.81 million$12.10 millionViewN/AView Earnings Details
3/13/2014Q313($0.18)($0.19)$8.99 million$10.25 millionViewN/AView Earnings Details
11/7/2013Q3 2013($0.28)($0.29)$2.45 million$6.60 millionViewN/AView Earnings Details
8/8/2013Q2 2013($0.30)($0.30)$0.10 million$0.02 millionViewN/AView Earnings Details
5/8/2013Q1 2013($0.26)($0.32)ViewN/AView Earnings Details
3/14/2013Q1 2013($0.27)($0.37)ViewN/AView Earnings Details
1/9/2013Q1 2013($0.23)($0.26)$0.25 millionViewN/AView Earnings Details
11/14/2012Q412($0.20)ViewN/AView Earnings Details
7/11/2012Q2 2012($0.18)($0.20)ViewN/AView Earnings Details
4/9/2012Q1 2012($0.18)($0.19)ViewN/AView Earnings Details
1/6/2012Q4 2011($0.23)($0.25)ViewN/AView Earnings Details
8/11/2009Q2 2009($0.65)ViewN/AView Earnings Details
5/1/2009Q1 2009($2.26)ViewN/AView Earnings Details
3/27/2009Q4 2008($3.21)ViewN/AView Earnings Details
11/12/2008Q3 2008($3.91)($5.82)ViewN/AView Earnings Details
8/8/2008Q2 2008($5.61)($8.04)ViewN/AView Earnings Details
5/13/2008Q1 2008($5.78)($4.20)ViewN/AView Earnings Details
3/26/2008Q4 2007($5.27)($8.81)ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Dividends

Raptor Pharmaceutical (NASDAQ:RPTP) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Raptor Pharmaceutical (NASDAQ RPTP) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 5.60%
Institutional Ownership Percentage: 54.88%
Insider Trading History for Raptor Pharmaceutical (NASDAQ:RPTP)
Insider Trading History for Raptor Pharmaceutical (NASDAQ:RPTP)

Raptor Pharmaceutical (NASDAQ RPTP) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
9/9/2015Suzanne Louise BruhnDirectorSell18,258$12.47$227,677.2648,437View SEC Filing  
9/2/2015Raymond AndersonDirectorSell4,916$12.51$61,499.166,695View SEC Filing  
8/31/2015Raymond AndersonDirectorSell8,084$12.52$101,211.686,695View SEC Filing  
7/1/2015Llew KeltnerDirectorSell50,000$16.05$802,500.00View SEC Filing  
6/18/2015Thomas E DaleyInsiderSell35,000$15.00$525,000.00View SEC Filing  
6/10/2015Suzanne Louise BruhnDirectorSell30,000$13.45$403,500.00View SEC Filing  
5/4/2015Richard L FranklinDirectorSell10,000$9.61$96,100.00View SEC Filing  
4/2/2015Richard L FranklinDirectorSell10,000$10.37$103,700.00View SEC Filing  
3/23/2015Christopher M StarrDirectorSell20,033$11.62$232,783.46View SEC Filing  
3/2/2015Richard L FranklinDirectorSell10,000$9.18$91,800.00View SEC Filing  
2/24/2015Christopher M StarrDirectorSell30,000$9.52$285,600.00View SEC Filing  
2/2/2015Richard L FranklinDirectorSell7,109$9.20$65,402.80View SEC Filing  
1/22/2015Christopher M StarrDirectorSell30,000$9.45$283,500.00View SEC Filing  
1/15/2015Christopher M StarrDirectorSell30,000$9.73$291,900.00View SEC Filing  
1/12/2015Raymond AndersonDirectorSell10,000$10.58$105,800.00View SEC Filing  
12/22/2014Christopher M StarrCEOSell30,000$9.00$270,000.00View SEC Filing  
12/15/2014Christopher M StarrCEOSell30,000$8.15$244,500.00View SEC Filing  
11/24/2014Christopher M StarrCEOSell30,000$9.97$299,100.00View SEC Filing  
10/22/2014Christopher M StarrCEOSell30,000$10.25$307,500.00View SEC Filing  
9/23/2014Christopher M StarrCEOSell30,000$10.21$306,300.00View SEC Filing  
9/16/2014Christopher M StarrCEOSell32,896$10.60$348,697.60View SEC Filing  
9/10/2014Raymond AndersonDirectorSell10,000$10.81$108,100.00View SEC Filing  
8/25/2014Erich SagerDirectorSell10,000$11.01$110,100.00View SEC Filing  
7/7/2014Llew KeltnerDirectorSell10,000$11.21$112,100.00View SEC Filing  
5/13/2014Georgia ErbezCFOBuy16,100$7.90$127,190.0016,100View SEC Filing  
4/7/2014Vijay SamantDirectorSell5,000$8.59$42,950.00View SEC Filing  
3/17/2014Christopher StarrCEOSell19,316$10.79$208,419.64699,370View SEC Filing  
1/13/2014Timothy WalbertDirectorSell5,520$15.06$83,131.20View SEC Filing  
1/9/2014Thomas DaleyInsiderSell15,000$14.17$212,550.0039,906View SEC Filing  
1/7/2014Llew KeltnerDirectorSell10,000$13.25$132,500.00View SEC Filing  
1/2/2014Richard FranklinDirectorSell10,715$13.12$140,580.80View SEC Filing  
12/9/2013Vijay SamantDirectorSell5,000$13.86$69,300.00View SEC Filing  
11/13/2013Timothy WalbertDirectorSell5,521$12.44$68,681.24View SEC Filing  
11/4/2013Richard FranklinDirectorSell10,715$14.88$159,439.20View SEC Filing  
10/15/2013Christopher M StarrCEOSell25,000$13.77$344,250.00View SEC Filing  
10/14/2013Suzanne Louise BruhnDirectorSell2,760$13.58$37,480.80View SEC Filing  
10/7/2013Vijay SamantDirectorSell5,000$14.76$73,800.00View SEC Filing  
9/16/2013Christopher StarrCEOSell25,000$14.21$355,250.00699,370View SEC Filing  
9/16/2013Erich SagerDirectorSell17,000$14.21$241,570.00130,727View SEC Filing  
9/13/2013Suzanne Louise BruhnDirectorSell2,760$14.07$38,833.20View SEC Filing  
9/9/2013Richard L FranklinDirectorSell10,715$14.24$152,581.60View SEC Filing  
9/9/2013Thomas E DaleyInsiderSell25,000$14.28$357,000.00View SEC Filing  
8/30/2013Georgia ErbezCFOSell7,400$13.42$99,308.00View SEC Filing  
12/28/2012Raymond AndersonDirectorSell2,000$5.50$11,000.00View SEC Filing  
11/26/2012Erich SagerDirectorSell11,279$5.00$56,395.00View SEC Filing  
9/12/2012Raymond AndersonDirectorSell2,000$5.50$11,000.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Raptor Pharmaceutical (NASDAQ RPTP) News Headlines

Source:

SEC Filings

Raptor Pharmaceutical (NASDAQ:RPTP) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Raptor Pharmaceutical (NASDAQ:RPTP) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Raptor Pharmaceutical (NASDAQ RPTP) Stock Chart for Tuesday, April, 24, 2018

Loading chart…

This page was last updated on 4/24/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.